SanBio Co. Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.51 |
Market Cap |
$1.65 B |
Shares Outstanding |
49.7 M |
Public Float |
- |
SanBio Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY56.69 |
Market Cap |
JPY182.36 B |
Shares Outstanding |
51.73 M |
Public Float |
26.71 M |
Address |
St. Luke Tower, 28/F Tokyo Tokyo 104 Japan |
Employees | - |
Website | http://www.sanbio.jp |
Updated | 07/08/2019 |
SanBio Co., Ltd. engages in the development and sale of regenerative cells pharmaceuticals. It also provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded by Keita Mori and Toru Kawanishi in February 2001 and is headquartered in Tokyo, Japan. |